LEADER IN ABUSE DETERRENT &
MULTI-PILL ABUSE RESISTANT TECHNOLOGIES
Ensysce is disrupting the field of abuse and overdose with its prodrug approach to prevention. Trypsin-Activated Abuse Protection (TAAP) prevents abuse through a 2-step internal Trypsin-Activation process. Multi-Pill Abuse Resistant overdose protection (MPAR™) provides a Trypsin inhibitor that limits activation with increasing ingestion of product.
Phase I Lead and Pipeline opioid and ADHD products can meet the medical needs of patients, while providing a solution to the national epidemic of prescription abuse.
These platforms are protected with world-wide patents, have been granted fast-track status by the FDA, and have been awarded a multi-year grant by the National Institute of Drug Abuse (NIDA).